Epernicus

Cambridge, United States Founded: 2007 • Age: 19 yrs Acquired By DrugDev
Social networking is provided for researchers and clinical trials.

About Epernicus

Epernicus is a Healthcare company based in Cambridge (United States) founded in 2007, and was acquired by DrugDev in May 2014. Social networking is provided for researchers and clinical trials. It operates in the Healthcare and Media & Entertainment sectors. The company has 1 employees. Its focus areas include Consumer, Social Platforms, Professionals and Researchers. Its competitors include IMS Health, Axtria and IntegriChain; 2 of its 3 listed competitors have raised funding.

Company details

Epernicus was founded in 2007 in Cambridge, United States, as a social networking platform tailored for research scientists. Connections among colleagues in scientific networks are facilitated, and expertise is located to support research advancement. The platform serves the biotechnology and clinical trials sector globally. Acquisition by DrugDev occurred in 2014, integrating its operations into broader drug development resources.

  • Headquarters Cambridge, United States
  • Employees 1
  • Stage Acquired
  • Sectors
    Healthcare
    Media & Entertainment
  • Website epernicus.com
  • Social X
  • Acquired by DrugDev (May 2014)
Key Metrics

Investors in Epernicus

Epernicus has secured backing from 1 investor. Prominent investors backing the company include DrugDev.

All
InvestorDescriptionFounded YearDomainLocation
Technology solutions for global clinical trials management are offered.
2008drugdev.comWayne, United States
Premium access

Investor details for Epernicus

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Epernicus

2 dated milestones of Epernicus across 7 years, from founding to its latest funding, stage changes and deals.

  1. Founded Epernicus is founded.
  2. Exit Acquired by DrugDev.

Competitors of Epernicus

Epernicus has 3 listed competitors in our database, 2 of them funded. They include IMS Health, Axtria and IntegriChain.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
imshealth.com1954Danbury, United States17,574
SaaS and AI-based market intelligence is provided for healthcare companies.
axtria.com2009Berkeley Heights, United States$198.74M749
Data analytics and AI solutions are provided for life sciences.
integrichain.com2005Philadelphia, United States$2M320
Inventory, order and customer relationship management solution for life science suppliers.
Premium access

Detailed competitors of Epernicus

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Epernicus

Websites that share an audience with Epernicus (epernicus.com).

Similar websites

Websites whose visitors overlap most with Epernicus. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
researchgate.net
100%
101.7M#345View details
biomedexperts.com
biomedexperts.com
100%
–
academia.edu
98%
26.5M#2,221View details
labmeeting.com
70%
View details

Top companies in Life Sciences Platforms & Tools

3 companies that operate in the same segment as Epernicus (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Medidata is recognized as a leading provider of SaaS solutions for clinical research.
1999New York, New York, United StatesUSD 41.5 M
AI-based solutions for health management are provided.
2015Dallas, Texas, United StatesUSD 2.8 B1,111
Real-world health data is provided for research and decisions.
2012Menlo Park, California, United StatesUSD 259.16 M
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Epernicus

Epernicus was founded in 2007.

Epernicus is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.

Epernicus has 1 employees.

Epernicus was founded in 2007 in Cambridge, United States, as a social networking platform tailored for research scientists. Connections among colleagues in scientific networks are facilitated, and expertise is located to support research advancement. The platform serves the biotechnology and clinical trials sector globally. Acquisition by DrugDev occurred in 2014, integrating its operations into broader drug development resources.

Epernicus's top competitors include Axtria, IntegriChain and IMS Health.

Epernicus has 1 investor. Key investors include DrugDev.

Yes. Epernicus was acquired by DrugDev in May 2014.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available